Amini Hassan, Rezaie Jafar, Vosoughi Armin, Rahbarghazi Reza, Nouri Mohammad
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Thoracic Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
J Cardiovasc Thorac Res. 2017;9(3):127-132. doi: 10.15171/jcvtr.2017.22. Epub 2017 Aug 28.
Stem cells (SCs) have special potency to differentiate into different types of cells, especially cardiomyocytes. In order to demonstrate the therapeutic applications of these cells, various investigations are recently being developed. Cardiac progenitor cells are endogenous cardiac SCs that found to express tyrosine kinase receptors, c-Kit and other stemness features in adult heart, contributing to the regeneration of cardiac tissue after injury. This lineage is able to efficiently trans-differentiate into different cell types such as cardiomyocytes, endothelial cells, and smooth muscle cells. Noticeably, several cardiac progenitor cells have been identified until yet. The therapeutic applications of cardiac SCs have been studied previously, which could introduce a novel therapeutic approach in the treatment of cardiac disorders. The current review enlightens the potency of cardiac progenitor cells features and differentiation capacity, with current applications in cardiovascular field.
干细胞具有分化为不同类型细胞的特殊能力,尤其是心肌细胞。为了证明这些细胞的治疗应用,最近正在开展各种研究。心脏祖细胞是内源性心脏干细胞,在成体心脏中被发现表达酪氨酸激酶受体、c-Kit以及其他干性特征,有助于损伤后心脏组织的再生。该谱系能够有效地转分化为不同的细胞类型,如心肌细胞、内皮细胞和平滑肌细胞。值得注意的是,到目前为止已经鉴定出几种心脏祖细胞。心脏干细胞的治疗应用此前已被研究,这可能为心脏病的治疗引入一种新的治疗方法。本综述阐述了心脏祖细胞的特性和分化能力,以及其在心血管领域的当前应用。